18 related articles for article (PubMed ID: 14506164)
1. Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity.
Pannucci NL; Li D; Sahay S; Thomas EK; Chen R; Tala I; Hu T; Ciccarelli BT; Megjugorac NJ; Adams Iii HC; Rodriguez PL; Fitzpatrick ER; Lagunoff D; Williams DA; Whitehead IP
Blood Cancer J; 2013 Aug; 3(8):e135. PubMed ID: 23955590
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia.
Burke BA; Carroll M
Leukemia; 2010 Jun; 24(6):1105-12. PubMed ID: 20445577
[TBL] [Abstract][Full Text] [Related]
3. Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.
Rink L; Slupianek A; Stoklosa T; Nieborowska-Skorska M; Urbanska K; Seferynska I; Reiss K; Skorski T
Blood; 2007 Jul; 110(2):651-60. PubMed ID: 17431132
[TBL] [Abstract][Full Text] [Related]
4. BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells.
Slupianek A; Nowicki MO; Koptyra M; Skorski T
DNA Repair (Amst); 2006 Feb; 5(2):243-50. PubMed ID: 16297667
[TBL] [Abstract][Full Text] [Related]
5. ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance?
Majsterek I; Slupianek A; Hoser G; Skórski T; Blasiak J
Biochimie; 2004 Jan; 86(1):53-65. PubMed ID: 14987801
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
7. STI571 reduces NER activity in BCR/ABL-expressing cells.
Sliwinski T; Czechowska A; Szemraj J; Morawiec Z; Skorski T; Blasiak J
Mutat Res; 2008 Jul; 654(2):162-7. PubMed ID: 18602021
[TBL] [Abstract][Full Text] [Related]
8. Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.
Czechowska A; Poplawski T; Drzewoski J; Blasiak J
Chem Biol Interact; 2005 Apr; 152(2-3):139-50. PubMed ID: 15840387
[TBL] [Abstract][Full Text] [Related]
9. Differential biologic effects of CPD and 6-4PP UV-induced DNA damage on the induction of apoptosis and cell-cycle arrest.
Lo HL; Nakajima S; Ma L; Walter B; Yasui A; Ethell DW; Owen LB
BMC Cancer; 2005 Oct; 5():135. PubMed ID: 16236176
[TBL] [Abstract][Full Text] [Related]
10. Impact of p210(Bcr-Abl) on ultraviolet C wavelength-induced DNA damage and repair.
Laurent E; Mitchell DL; Estrov Z; Lowery M; Tucker SL; Talpaz M; Kurzrock R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3722-30. PubMed ID: 14506164
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
